ICD-10 Coding for Hyperlipidemia Screening(E78.0, E78.01, E78.01B)
Learn about ICD-10 coding for hyperlipidemia screening, including code Z13.220 for asymptomatic lipid disorder screening.
Complete code families applicable to Hyperlipidemia Screening
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z13.220 | Encounter for screening for lipoid disorders | Use for asymptomatic patients undergoing routine lipid screening. |
|
| E78.01 | Familial hypercholesterolemia | Use when familial hypercholesterolemia is confirmed by genetic testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHyperlipidemia Screening
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hyperlipidemia Screening.
Vague documentation such as 'check lipids'.
Impact
Clinical: May lead to incorrect coding., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Use specific terms indicating screening intent
Using Z13.220 for follow-up of known hyperlipidemia.
Impact
Reimbursement: Claims may be denied if Z13.220 is used incorrectly., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate data on patient health status.
Mitigation
Use E78.x codes for follow-up and management of diagnosed hyperlipidemia.
Incorrect use of screening codes
Impact
Using Z13.220 for patients with known hyperlipidemia.
Mitigation
Ensure documentation supports the use of screening codes.